Bilateral Priming for Upper Extremity Hemiparesis in Older Adults
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02277028 |
Recruitment Status :
Completed
First Posted : October 28, 2014
Last Update Posted : May 25, 2016
|
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Stroke, Upper Extremity Hemiparesis | Behavioral: priming and task specific training | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 18 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | A Comparison of Two Types of Priming for Upper Extremity Hemiparesis |
Study Start Date : | April 2014 |
Actual Primary Completion Date : | February 2016 |
Actual Study Completion Date : | April 2016 |
Arm | Intervention/treatment |
---|---|
Experimental: Bilateral Priming
Bilateral priming a priming technique which is non-invasive and free of side effects. The technique described in this study uses bilateral, symmetrical, rhythmic movement "bilateral priming" and its purpose is to ready the motor cortex for functional limb training. A "rocker" is used so that the less affected limb can drive the affected one in symmetrical wrist flexion and extension. The priming (15 minutes) will be following by task specific training (45 minutes). Subjects will then have a break (betw. 30-60 minutes) and then repeat the above. Total priming for one day is 30 minutes. Total task specific training for one day is 90 minutes
|
Behavioral: priming and task specific training
This task specific training protocol has been used in several clinical trials. |
Active Comparator: Health Education
The group with no priming will receive stroke related health education via a website from the American Heart Association (15 minutes). They will use their affected hand (as they are able) This will be followed by 45 minutes of the same task specific arm training protocol described in the bilateral priming group. This group will follow the same schedule as above. The health education (15 minutes) will be following by task specific training (45 minutes). Subjects will then have a break (betw. 30-60 minutes) and then repeat the above. Total time on health education website for one day is 30 minutes. Total task specific training for one day is 90 minutes
|
Behavioral: priming and task specific training
This task specific training protocol has been used in several clinical trials. |
- Chedoke Arm and Hand Activity Index [ Time Frame: 6-8 weeks ]Test of bilateral hand function
- Fugl Meyer Upper Extremity Scale [ Time Frame: 6-8 weeks ]Test of unilateral hand/arm function

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 55 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Must have survived a unilateral stroke at least six months prior to enrollment
- Fugl Meyer Upper Extremity Score between 22-38.
Exclusion Criteria:
- No individuals who have a pacemaker, metal implant in head or neck, history of seizures, recent concussion or history of headaches

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02277028
United States, Illinois | |
Rush University Medical Center | |
Chicago, Illinois, United States, 60612 |
Principal Investigator: | Mary E Stoykov, PhD | Rush University |
Responsible Party: | Rush University Medical Center |
ClinicalTrials.gov Identifier: | NCT02277028 |
Other Study ID Numbers: |
AOTFIRG13STOYKOV |
First Posted: | October 28, 2014 Key Record Dates |
Last Update Posted: | May 25, 2016 |
Last Verified: | May 2016 |
Paresis Neurologic Manifestations Nervous System Diseases |